Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. - Back NK; Berkhout B (Antimicrobial agents and chemotherapy, 1997)